New study aims to tell which baby birthmarks need treatment
NCT ID NCT07669545
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study will follow 150 infants with a type of birthmark called infantile hemangioma. Some have a less active form that barely grows, while others have the typical form. Doctors will assess each baby using standard guidelines and decide whether to recommend treatment or just watch and wait. The goal is to learn whether the less active form truly needs less intervention, helping families avoid unnecessary treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better identify which infantile hemangiomas need treatment and which can be safely observed, reducing unnecessary interventions.
- What could go wrong
- This is an observational study, not a treatment trial. It will not test any new therapy, and its findings may not change current practice immediately.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFANTILE HEMANGIOMA (IH) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
West China Hospital of Sichuan University
Chengdu, Sichuan, 610041, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.